---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-25-000178"
form_type: "8-K"
ticker: null
cik: "0001708331"
company_name: "Virpax Pharmaceuticals, Inc."
filed_at: "2025-02-06T23:59:59+00:00"
generated_at: "2026-05-27T01:42:21.877435+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Virpax appoints Charn Deol to board; Jaydriane Panis resigns

## Summary
- Jaydriane Panis resigned from board on Feb 3, 2025; Charn Deol appointed Feb 5, 2025.
- Deol appointed Chair of Audit Committee, member of Compensation and Nominating Committees.
- Deol receives CAD $3,000/month consulting fee payable to Spiral Investment Corp., his company.
- Deol has over 35 years public company experience, currently director/CFO at several companies.

## SEC filing metadata
- accession: 0001731122-25-000178
- form_type: 8-K
- cik: 0001708331
- company_name: Virpax Pharmaceuticals, Inc.
- filed_at: 2025-02-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708331/000173112225000178/0001731122-25-000178-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708331/000173112225000178/e6344_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-25-000178
- JSON: https://secwatch.observer/filing/0001731122-25-000178.json
- Plain text: https://secwatch.observer/filing/0001731122-25-000178.txt

## Key facts
- Executive change
  Jaydriane Panis resigned as Director at Virpax Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Director
  source text: Jaydriane (Jay) Panis, who resigned from the Board on February 3, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708331/000173112225000178/0001731122-25-000178-index.htm
- Executive change
  Charn Deol was appointed as Director at Virpax Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Mr. Charn Deol as an independent director of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708331/000173112225000178/0001731122-25-000178-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.